Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Go back to Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
(NASDAQ: LEXX) Delayed: 0.61 -0.03 (4.69%)
Previous Close $0.64    52 Week High
Open $0.64    52 Week Low
Day High $0.65    P/E N/A 
Day Low $0.61    EPS
Volume 82,390       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 44,397